Problem Solving in Haematology.pdf

(10652 KB) Pobierz
ProblemSolving in
Haematology
G R A E M E S M I T H
C L I N I C A L
P U B L I S H I N G
1306052781.185.png 1306052781.195.png 1306052781.206.png 1306052781.217.png 1306052781.001.png 1306052781.012.png 1306052781.022.png
 
1306052781.043.png 1306052781.054.png 1306052781.064.png 1306052781.075.png 1306052781.086.png 1306052781.097.png 1306052781.107.png 1306052781.118.png 1306052781.129.png 1306052781.140.png 1306052781.149.png 1306052781.150.png 1306052781.151.png 1306052781.152.png 1306052781.153.png 1306052781.154.png 1306052781.155.png 1306052781.156.png 1306052781.157.png 1306052781.158.png 1306052781.159.png 1306052781.160.png 1306052781.161.png 1306052781.162.png 1306052781.163.png 1306052781.164.png 1306052781.165.png 1306052781.166.png 1306052781.167.png 1306052781.168.png 1306052781.169.png 1306052781.170.png 1306052781.171.png 1306052781.172.png 1306052781.173.png 1306052781.174.png 1306052781.175.png 1306052781.176.png 1306052781.177.png 1306052781.178.png 1306052781.179.png 1306052781.180.png 1306052781.181.png 1306052781.182.png 1306052781.183.png 1306052781.184.png 1306052781.186.png 1306052781.187.png 1306052781.188.png 1306052781.189.png 1306052781.190.png 1306052781.191.png 1306052781.192.png 1306052781.193.png
 
Problem Solving in
Haematology
GRAEME SMITH
Consultant Haematologist, Clinical Director, Department of Haematology,
St James’s Institute of Oncology, Leeds, UK
CLINICAL PUBLISHING
OXFORD
1306052781.194.png 1306052781.196.png 1306052781.197.png 1306052781.198.png 1306052781.199.png 1306052781.200.png 1306052781.201.png 1306052781.202.png 1306052781.203.png 1306052781.204.png 1306052781.205.png 1306052781.207.png 1306052781.208.png 1306052781.209.png 1306052781.210.png 1306052781.211.png 1306052781.212.png 1306052781.213.png 1306052781.214.png 1306052781.215.png 1306052781.216.png 1306052781.218.png 1306052781.219.png 1306052781.220.png 1306052781.221.png 1306052781.222.png 1306052781.223.png 1306052781.224.png 1306052781.225.png 1306052781.226.png 1306052781.227.png 1306052781.002.png 1306052781.003.png 1306052781.004.png 1306052781.005.png 1306052781.006.png 1306052781.007.png 1306052781.008.png 1306052781.009.png 1306052781.010.png 1306052781.011.png 1306052781.013.png 1306052781.014.png
 
CLINICAL PUBLISHING
an imprint of Atlas Medical Publishing Ltd
Oxford Centre for Innovation
Mill Street, Oxford OX2 0JX, UK
tel: +44 1865 811116
fax: +44 1865 251550
email: info@clinicalpublishing.co.uk
web: www.clinicalpublishing.co.uk
Distributed in USA and Canada by:
Clinical Publishing
30 Amberwood Parkway
Ashland OH 44805 USA
tel: 800-247-6553 (toll free within US and Canada)
fax: 419-281-6883
email: order@bookmasters.com
Distributed in UK and Rest of World by:
Marston Book Services Ltd
PO Box 269
Abingdon
Oxon OX14 4YN
UK
tel: +44 1235 465500
fax: +44 1235 465555
email: trade.orders@marston.co.uk
© Atlas Medical Publishing Ltd 2010
First published 2010
All rights reserved. No part of this publication may be reproduced, stored in a
retrieval system, or transmitted, in any form or by any means, without the prior
permission in writing of Clinical Publishing or Atlas Medical Publishing Ltd.
Although every effort has been made to ensure that all owners of copyright material
have been acknowledged in this publication, we would be glad to acknowledge
in subsequent reprints or editions any omissions brought to our attention.
Clinical Publishing and Atlas Medical Publishing Ltd bear no responsibility for the
persistence or accuracy of URLs for external or third-party internet websites referred
to in this publication, and does not guarantee that any content on such websites is,
or will remain, accurate or appropriate.
A catalogue record for this book is available from the British Library.
ISBN 13
978 1 84692 005 9
ISBN e-book
978 1 84692 605 1
The publisher makes no representation, express or implied, that the dosages in this book
are correct. Readers must therefore always check the product information and clinical
procedures with the most up-to-date published product information and data sheets
provided by themanufacturers and the most recent codes of conduct and safety
regulations. The authors and the publisher do not accept any liability for any errors
in the text or for the misuse or misapplication of material in this work.
Project manager: Gavin Smith, GPS Publishing Solutions, Herts, UK
Typeset by Phoenix Photosetting, Chatham, UK
Printed by Marston Book Services, Abingdon, Oxon, UK
1306052781.015.png 1306052781.016.png 1306052781.017.png 1306052781.018.png 1306052781.019.png 1306052781.020.png 1306052781.021.png 1306052781.023.png 1306052781.024.png 1306052781.025.png 1306052781.026.png 1306052781.027.png 1306052781.028.png 1306052781.029.png 1306052781.030.png 1306052781.031.png 1306052781.032.png 1306052781.033.png 1306052781.034.png 1306052781.035.png 1306052781.036.png 1306052781.037.png 1306052781.038.png 1306052781.039.png 1306052781.040.png 1306052781.041.png 1306052781.042.png 1306052781.044.png 1306052781.045.png 1306052781.046.png 1306052781.047.png 1306052781.048.png 1306052781.049.png 1306052781.050.png 1306052781.051.png 1306052781.052.png 1306052781.053.png 1306052781.055.png 1306052781.056.png 1306052781.057.png
 
Contents
Contributors
vii
Abbreviations
ix
Introduction
SECTION 1
1.
The approach to the patient with an abnormal blood count, G Smith
1
Haemostasis and Thrombosis
SECTION 2
2.
Anticoagulation, L Newton
7
3.
Bleeding in an intensive therapy unit patient, C Millar
14
4.
Investigation of easy bruising, L Newton
21
5.
Inherited disorders of coagulation, L Newton
26
6.
Thrombophilia, L Newton
32
Red Cell Disorders and Aplastic Anaemia
SECTION 3
7.
The investigation of anaemia and the anaemia of chronic
disease, G Smith
41
8.
Aplastic anaemia, P Hillmen
45
9.
Paroxysmal nocturnal haemoglobinuria, P Hillmen
50
10.
Sickle cell disease, A Critchley
54
11 .
β
-Thalassaemia major, Q Hill
62
SECTION 4 Clinical Blood Transfusion
12. Acute haemolytic transfusion reaction (ABO incompatibility),
D Norfolk 71
13. Massive blood transfusion, D Norfolk 76
14. Refractoriness to platelet alloimmunization, D Norfolk
80
15. Transfusion-related acute lung injury, D Norfolk
85
SECTION 5 Acute and Chronic Leukaemia and
Myelodysplasia
16. Acute myeloid leukaemia, D Bowen 89
17. Paediatric acute lymphoblastic leukaemia, S Kinsey
94
18. Adult acute lymphoblastic leukaemia, M Gilleece
98
1306052781.058.png 1306052781.059.png 1306052781.060.png 1306052781.061.png 1306052781.062.png 1306052781.063.png 1306052781.065.png 1306052781.066.png 1306052781.067.png 1306052781.068.png 1306052781.069.png 1306052781.070.png 1306052781.071.png 1306052781.072.png 1306052781.073.png 1306052781.074.png 1306052781.076.png 1306052781.077.png 1306052781.078.png 1306052781.079.png 1306052781.080.png 1306052781.081.png 1306052781.082.png 1306052781.083.png 1306052781.084.png 1306052781.085.png 1306052781.087.png 1306052781.088.png 1306052781.089.png 1306052781.090.png 1306052781.091.png 1306052781.092.png 1306052781.093.png 1306052781.094.png 1306052781.095.png 1306052781.096.png 1306052781.098.png 1306052781.099.png 1306052781.100.png 1306052781.101.png 1306052781.102.png 1306052781.103.png
 
vi
Contents
19. Chronic lymphocytic leukaemia – early stage disease, P Hillmen 101
20. Chronic lymphocytic leukaemia – advanced stage disease, P Hillmen
105
21. Chronic myeloid leukaemia, G Smith 110
22. Low-risk myelodysplastic syndrome, D Bowen
11 5
SECTION 6 Myeloproliferative Disorders
23. Primary polycythaemia, D Swirsky
11 9
24. Primary myelofibrosis, Q Hill 123
25. Essential thrombocythaemia, Q Hill
128
26. Hypereosinophilic syndrome, G Smith
133
SECTION 7 Lymphoma
27. Hodgkin lymphoma – early stage disease, D Gilson 137
28. Hodgkin lymphoma – advanced stage disease and long-term sequelae,
D Gilson 143
29. High-grade diffuse large B-cell non-Hodgkin’s lymphoma, R Johnson
148
30. Primary central nervous system lymphoma, R Johnson
153
31.
Indolent lymphoma – follicular non-Hodgkin lymphoma, R Johnson
158
32. Indolent lymphoma – Waldenström’s macroglobulinaemia epistaxis,
R Owen
163
SECTION 8 Plasma Cell Disorders
33. Myeloma – diagnosis and prognosis, G Cook, S Feyler
169
34. Myeloma – management, G Cook, S Feyler 174
35. Myeloma – treatment in the less fit or compromised patient,
G Cook, S Feyler 180
36. Myeloma – solitary plasmacytoma, G Cook, S Feyler
183
37. Myeloma – AL amyloid, G Cook, S Feyler
187
General index
193
1306052781.104.png 1306052781.105.png 1306052781.106.png 1306052781.108.png 1306052781.109.png 1306052781.110.png 1306052781.111.png 1306052781.112.png 1306052781.113.png 1306052781.114.png 1306052781.115.png 1306052781.116.png 1306052781.117.png 1306052781.119.png 1306052781.120.png 1306052781.121.png 1306052781.122.png 1306052781.123.png 1306052781.124.png 1306052781.125.png 1306052781.126.png 1306052781.127.png 1306052781.128.png 1306052781.130.png 1306052781.131.png 1306052781.132.png 1306052781.133.png 1306052781.134.png 1306052781.135.png 1306052781.136.png 1306052781.137.png 1306052781.138.png 1306052781.139.png 1306052781.141.png 1306052781.142.png 1306052781.143.png 1306052781.144.png 1306052781.145.png 1306052781.146.png 1306052781.147.png 1306052781.148.png
 
Zgłoś jeśli naruszono regulamin